Non-neurodestructive ganglion impar blocks for coccydynia and related disorders: a systematic review and meta-analysis
Authors' conclusion
Non-neurodestructive GIB may be a safe and potentially effective treatment option for patients with chronic, refractory coccydynia.
Study context
- Population
- Patients with chronic coccydynia
- Participants
- 625 patients · 17 studies
- Comparison
- Pain before vs after non-neurodestructive ganglion impar block
- GIBn = 625
- Outcome
- Coccygeal pain (VAS or NRS, 0 to 10), change from baseline
Methodological detailsPRISMA, GRADE assessment
- PRISMA
- GRADE assessment
Pooled result
As reported in the abstract
Coccygeal pain vs baseline (meta-analysis, 11 studies, 391 patients; baseline pain 7.93, 95% CI 7.81 to 8.04)
GIBSMD (95% CI)
Short-term (up to 3 months)
−2.73(−3.45 to −2.01)
Intermediate-term (3-6 months)
−2.13(−2.82 to −1.45)
Long-term (>6 months)
−1.86(−2.58 to −1.15)
Safety
- No serious adverse events were noted
Original publication
Non-neurodestructive ganglion impar blocks for coccydynia and related disorders: a systematic review and meta-analysis. Reg Anesth Pain Med. Published 12 March 2025. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →